Alembic gets USFDA nod for generic ophthalmic solution

Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Alcaftadine ophthalmic solution, in the American market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cyGrZq
via IFTTT